Freeline Therapeutics Holdings (Freeline Therapeutics Holdings) Market Cap : $28.46 Mil (As of Jun. 08, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Freeline Therapeutics Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Freeline Therapeutics Holdings's share price for the quarter that ended in Sep. 2023 was $4.3. Freeline Therapeutics Holdings's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 4.36 Mil. Therefore, Freeline Therapeutics Holdings's market cap for the quarter that ended in Sep. 2023 was $18.74 Mil.

Freeline Therapeutics Holdings's quarterly market cap declined from Mar. 2023 ($29.65 Mil) to Jun. 2023 ($11.24 Mil) but then increased from Jun. 2023 ($11.24 Mil) to Sep. 2023 ($18.74 Mil).

Freeline Therapeutics Holdings's annual market cap declined from Dec. 2020 ($654.71 Mil) to Dec. 2021 ($70.99 Mil) and declined from Dec. 2021 ($70.99 Mil) to Dec. 2022 ($30.94 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Freeline Therapeutics Holdings's Enterprise Value for Today is $2.99 Mil.

Freeline Therapeutics Holdings Market Cap Historical Data

The historical data trend for Freeline Therapeutics Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Freeline Therapeutics Holdings Market Cap Chart

Freeline Therapeutics Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Market Cap

654.71

70.99

30.94

Freeline Therapeutics Holdings Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Market Cap	Get a 7-Day Free Trial													45.48	30.94	29.65	11.24	18.74

Competitive Comparison of Freeline Therapeutics Holdings's Market Cap

For the Biotechnology subindustry, Freeline Therapeutics Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Freeline Therapeutics Holdings's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Freeline Therapeutics Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Freeline Therapeutics Holdings's Market Cap falls into.

Freeline Therapeutics Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Freeline Therapeutics Holdings's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )	=	Share Price (A: Dec. 2022 )	*	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	$7.1265	*	4.3409
	=	$30.94

Freeline Therapeutics Holdings's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )	=	Share Price (Q: Sep. 2023 )	*	Shares Outstanding (EOP) (Q: Sep. 2023 )
	=	$4.3	*	4.35795
	=	$18.74

Freeline Therapeutics Holdings (NAS:FRLN) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Freeline Therapeutics Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Freeline Therapeutics Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Freeline Therapeutics Holdings (Freeline Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Freeline Therapeutics Holdings PLC (NAS:FRLN) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gunnels Wood Road, Sycamore House, Stevenage, Hertfordshire, GBR, SG1 2BP

Website

https://www.freeline.life

Freeline Therapeutics Holdings PLC is a clinical-stage biotechnology company developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its lead product candidates are FLT180a for the treatment of hemophilia B, FLT190 for the treatment of Fabry disease and FLT201 for the treatment of Gaucher disease Type 1.